Centre for Genomics, Evolution and Medicine, University of Tartu, together with The Nordic Society of Human Genetics and Precision Medicine (NSHG-PM), successfully concluded a joint workshop, "Precision Medicine: The Bridge from Research to Healthcare," held in Tallinn, Estonia. The event, which took place from June 19–21, brought together scientists, clinicians, and young researchers to discuss the latest advancements and future prospects in precision medicine.
The new approach includes interactive workshops on pivotal topics for personalised medicine, machine learning, Mendelian randomisation, and polygenic risk scores (PRS) to the meticulously designed programme and keynote presentations. Several young researchers were offered the opportunity to present their research projects to clinicians and top researchers in the field.
A poster session provided a platform for 27 young researchers to present their latest findings, while six presenters had the opportunity to deliver short talks to the engaged audience. The NSHG-PM workshop facilitated invaluable networking opportunities, bringing together human geneticists, big data scientists, biobankers, epidemiologists, hospital clinicians, biomedical industry researchers, and executives.
Key topics addressed during the workshop included the implementation of polygenic risk scores and pharmacogenomics in clinical settings, personalised approaches in cardiometabolic disorders, and the effects of environmental factors on human health. Renowned speakers from esteemed institutions such as the University of Edinburgh, Karolinska Institutet, Uppsala University, University of Tartu, and the University of Oslo, among others, shared their expertise and insights. Much focus was on advancing international collaboration, especially within Europe. The event held back-to-back with EU-funded research projects CoMorMent, Realment and Covidment’s Annual meetings, provided opportunities to advance collaboration on topics of mutual interest in the field of personalised medicine. Moreover, several other EU-funded projects, such as the SafePolyMed project, were found to be very relevant for the NSHG-PM society in the near future. In addition, the Industry Forum participants added insight into the most recent advancements in the technological field that can further be exploited. For a more detailed overview, please find the abstract book: https://nshg-pm2023.org/wp-content/uploads/2023/06/CAP-Partner_NSHG-PM2023_abstract-book.pdf
Looking ahead, the NSHG-PM has already begun preparations for its next conference, which will take place in Trondheim, Norway, from September 10–12, 2024. With an aim to fuel future advancements in public health, clinical care, and innovation, the upcoming conference promises to be another milestone event for the Nordic region.
The Institute of Genomics, Centre for Genomics, Evolution and Medicine and NSHG-PM extend their gratitude to all participants, sponsors, and partners who made the Tallinn workshop a resounding success.
The workshop took place within H2020 grants cGEM, no 810645, and many talks were presenting the results of the CoMorMent project, H2020 grant no 847776.
→ For further updates on the NSHG-PM and information about the forthcoming conference in Trondheim, please visit our website: https://www.nshg-pm.org/.
→ For further events organised by the Centre for Genomics, Evolution and Medicine (University of Tartu, Institute of Genomics) please visit our website https://cgem.ut.ee.